Boxer Capital as of Dec. 31, 2021
Portfolio Holdings for Boxer Capital
Boxer Capital holds 71 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mirati Therapeutics | 11.4 | $293M | 2.0M | 146.69 | |
| Spdr Ser Tr S&p Biotech (XBI) | 9.6 | $246M | 2.2M | 111.96 | |
| Iteos Therapeutics | 7.9 | $202M | 4.3M | 46.56 | |
| BeiGene Sponsored Adr (ONC) | 5.3 | $136M | 500k | 270.93 | |
| Springworks Therapeutics (SWTX) | 5.0 | $129M | 2.1M | 61.98 | |
| Cytokinetics Com New (CYTK) | 3.7 | $96M | 2.1M | 45.58 | |
| Tyra Biosciences (TYRA) | 3.5 | $91M | 6.4M | 14.07 | |
| Revolution Medicines (RVMD) | 3.4 | $88M | 3.5M | 25.17 | |
| Relay Therapeutics (RLAY) | 3.2 | $82M | 2.7M | 30.71 | |
| Tango Therapeutics (TNGX) | 2.9 | $75M | 6.9M | 10.94 | |
| Pmv Pharmaceuticals (PMVP) | 2.5 | $66M | 2.8M | 23.10 | |
| Spdr Ser Tr Call Call Option | 2.4 | $62M | 550k | 111.96 | |
| Merus N V (MRUS) | 2.3 | $60M | 1.9M | 31.80 | |
| Arcus Biosciences Incorporated (RCUS) | 2.3 | $58M | 1.4M | 40.47 | |
| Blueprint Medicines (BPMC) | 2.1 | $54M | 507k | 107.11 | |
| Ideaya Biosciences (IDYA) | 2.0 | $52M | 2.2M | 23.64 | |
| Sage Therapeutics (SAGE) | 1.8 | $47M | 1.1M | 42.54 | |
| Anaptysbio Inc Common (ANAB) | 1.8 | $45M | 1.3M | 34.75 | |
| Nuvation Bio Com Cl A (NUVB) | 1.4 | $37M | 4.3M | 8.50 | |
| Nurix Therapeutics (NRIX) | 1.4 | $36M | 1.2M | 28.95 | |
| Kinnate Biopharma | 1.3 | $33M | 1.8M | 17.72 | |
| Rocket Pharmaceuticals (RCKT) | 1.2 | $32M | 1.5M | 21.83 | |
| Fate Therapeutics (FATE) | 1.1 | $29M | 500k | 58.51 | |
| Gossamer Bio (GOSS) | 1.1 | $28M | 2.5M | 11.31 | |
| Amicus Therapeutics (FOLD) | 1.0 | $27M | 2.3M | 11.55 | |
| Avidity Biosciences Ord (RNA) | 1.0 | $27M | 1.1M | 23.77 | |
| Bellus Health Com New | 1.0 | $26M | 3.2M | 8.05 | |
| GH Research Ordinary Shares (GHRS) | 0.9 | $24M | 1.0M | 23.33 | |
| Nuvalent Inc-a (NUVL) | 0.9 | $23M | 1.2M | 19.04 | |
| Iovance Biotherapeutics (IOVA) | 0.8 | $21M | 1.1M | 19.09 | |
| Day One Biopharmaceuticals I (DAWN) | 0.8 | $20M | 1.2M | 16.85 | |
| Xenon Pharmaceuticals (XENE) | 0.7 | $19M | 600k | 31.24 | |
| Aligos Therapeutics | 0.7 | $18M | 1.5M | 11.87 | |
| Akero Therapeutics (AKRO) | 0.7 | $18M | 832k | 21.15 | |
| Ultragenyx Pharmaceutical (RARE) | 0.7 | $17M | 200k | 84.09 | |
| Cullinan Oncology (CGEM) | 0.6 | $17M | 1.1M | 15.43 | |
| Rain Therapeutics | 0.6 | $15M | 1.2M | 12.88 | |
| Prothena Corporation SHS (PRTA) | 0.6 | $15M | 300k | 49.40 | |
| Milestone Pharmaceuticals (MIST) | 0.6 | $15M | 2.2M | 6.55 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.5 | $14M | 1.3M | 11.26 | |
| Point Biopharma Global | 0.5 | $14M | 2.5M | 5.60 | |
| Bioatla (BCAB) | 0.5 | $14M | 686k | 19.63 | |
| Theseus Pharmaceuticals | 0.4 | $11M | 892k | 12.68 | |
| Black Diamond Therapeutics (BDTX) | 0.4 | $11M | 2.0M | 5.33 | |
| Selecta Biosciences | 0.4 | $11M | 3.3M | 3.26 | |
| Essa Pharma Com New (EPIX) | 0.4 | $10M | 725k | 14.20 | |
| Codiak Biosciences | 0.4 | $9.5M | 850k | 11.14 | |
| Ngm Biopharmaceuticals | 0.3 | $8.9M | 500k | 17.71 | |
| Biomea Fusion (BMEA) | 0.3 | $8.9M | 1.2M | 7.45 | |
| MEI Pharma Com New | 0.3 | $7.8M | 2.9M | 2.67 | |
| Eqrx | 0.3 | $6.8M | 1.0M | 6.82 | |
| Atreca Cl A Com (BCEL) | 0.3 | $6.7M | 2.2M | 3.03 | |
| Odonate Therapeutics Ord | 0.2 | $5.7M | 4.2M | 1.35 | |
| Solid Biosciences | 0.2 | $5.6M | 3.2M | 1.75 | |
| Elevation Oncology (ELEV) | 0.2 | $5.3M | 873k | 6.02 | |
| BCLS Acquisition Corp Com Cl A | 0.2 | $4.9M | 500k | 9.80 | |
| JIYA Acquisition Corp Com Cl A | 0.2 | $4.9M | 500k | 9.77 | |
| Research Alliance Corp II Com Cl A | 0.2 | $4.9M | 500k | 9.77 | |
| Panacea Acquisition Corp II Cl A Shs | 0.2 | $4.9M | 500k | 9.70 | |
| ACADIA Pharmaceuticals (ACAD) | 0.2 | $4.3M | 185k | 23.34 | |
| Health Sciences Acquisition Corp II Ord Shs | 0.2 | $4.0M | 400k | 10.08 | |
| Helix Acquisition Corp Com Cl A | 0.2 | $4.0M | 400k | 9.89 | |
| Gemini Therapeutics | 0.1 | $3.8M | 1.3M | 2.91 | |
| DBV Technologies SA Sponsored Adr | 0.1 | $3.4M | 2.1M | 1.60 | |
| Oric Pharmaceuticals (ORIC) | 0.1 | $2.9M | 200k | 14.70 | |
| Cabaletta Bio (CABA) | 0.1 | $2.0M | 540k | 3.79 | |
| Omega Alpha SPAC Cl A | 0.1 | $2.0M | 200k | 9.77 | |
| Protara Therapeutics Com Stk (TARA) | 0.1 | $1.4M | 209k | 6.75 | |
| Genocea Biosciences Com New (GNCAQ) | 0.1 | $1.3M | 1.1M | 1.16 | |
| Surrozen | 0.1 | $1.3M | 200k | 6.44 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $504k | 267k | 1.89 |